GeneDx Holdings Corp. (WGS)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Total revenue | 102,692 | 87,115 | 76,874 | |
| Cost of services | 31,790 | 28,639 | 29,045 | |
| Gross profit | 70,902 | 58,476 | 47,829 | |
| General and administrative | 27,415 | 32,134 | 26,145 | |
| Research and development | 15,079 | 12,577 | 11,665 | |
| Selling and marketing | 19,448 | 18,316 | 17,025 | |
| Other operating expenses, net | - | - | -774 | |
| Income (loss) from operations | 8,960 | -4,551 | -7,780 | |
| Change in fair value of warrants and contingent liabilities | 2,181 | -1,100 | -880 | |
| Other income (expense), net | 239 | 209 | 1,144 | |
| Interest expense, net | -817 | -640 | -843 | |
| Total non-operating income (expense), net | 1,603 | -1,531 | -579 | |
| Income (loss) before income taxes | 10,563 | -6,082 | -8,359 | |
| Income tax benefit (expense) | -246 | 447 | -47 | |
| Net income (loss) | 10,809 | -6,529 | -8,312 | |
| Unrealized (loss) gain related to available for sale securities, net | -93 | 75 | 459 | |
| Comprehensive income (loss) | 10,716 | -6,454 | -7,853 | |
| Earnings (loss) per share, class a common stock- basic (in dollars per share) | 0.38 | -0.23 | -0.31 | |
| Earnings (loss) per share, class a common stock- diluted (in dollars per share) | 0.36 | -0.23 | -0.31 | |
| Weighted average shares outstanding of class a common stock - basic (in shares) | 28,579,704 | 28,147,948 | 27,095,986 | |
| Weighted average shares outstanding of class a common stock - diluted (in shares) | 29,753,933 | 28,147,948 | 27,095,986 | |